Crash Course
The Handmaid's Tale, Part 2: Crash Course Literature 404
This week, John Green continues to teach you about Margaret Atwood's speculative fiction, The Handmaid's Tale. In this installment, we're looking at Atwood's desire to tell a story from a female point of view, and what exactly it means...
TED-Ed
TED-ED: Why should you read "The Handmaid's Tale"? - Naomi R. Mercer
Margaret Atwood's speculative fiction masterpiece The Handmaid's Tale explores the consequences of complacency and how power can be wielded unfairly. Atwood's chilling vision of a dystopian regime has captured readers' imaginations since...
Healthcare Triage
Old Drugs, New Tricks: Remdesivir and Other Potential Treatments for COVID19
As the coronavirus and COVID19 pandemic continues, researchers are investigating some older drugs that may be viable treatments for the disease. One drug of interest is remdesivir, a decade old drug intended to treat hepatitis. It was...
TLDR News
Trials Underway for Coronavirus Treatments & Vaccines: Are We Getting Close? - TLDR News
Trials Underway for Coronavirus Treatments & Vaccines: Are We Getting Close? - TLDR News
Next Animation Studio
Explainer: What is Remdesivir and how does it treat COVID-19
Gilead’s remdesivir is an antiviral nucleoside analogue that disrupts a virus’s ability to replicate its genome.
Curated Video
FDA Green Lights Potential Coronavirus Recovery Drug
The FDA approved emergency use its anti-viral drug for further testing on those with severe cases requiring them to be on breathing support.
Bloomberg
Gilead to Buy Kite for $11.9 Billion in Cancer Megadeal
Aug.28 -- Bloomberg’s Taylor Riggs discusses a Gilead Sciences-Kite Pharma deal. She speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Bloomberg
China Seals Off County of 400,000 to Stem Beijing Cluster
Jun.30 -- China put 400,000 residents of a northern county under lockdown over the weekend after at least a dozen coronavirus cases associated with the Beijing outbreak were reported there. Bloomberg's Selina Wang has the story.
Curated Video
Official: U.S. Supply Of COVID-19 Drug Could Run Out Soon
An official from the Department of Health and Human Services says the last shipment of the COVID-19 treatment drug will be sent the week of June 29.
Curated Video
Gilead Shares Early Results Of Remdesivir Trial In COVID-19 Patients
Patients given remdesivir for five days had improved symptoms compared to those who were only given standard care.
Bloomberg
50% Chance Gilead's Coronavirus Drug Will Work: RBC Analyst
Brian Abrahams, RBC Capital Markets co-head of biotechnology research, discusses his call for the performance of Gilead Sciences's��experimental coronavirus therapy on "Bloomberg Markets: The Close." (Source: Bloomberg)
Bloomberg
AstraZeneca Is Said to Approach Gilead About Potential Merger
Jun.07 -- AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter. Su Keenan reports on "Bloomberg Daybreak: Australia."
Bloomberg
The Top Ten Stocks for Dec. 26
Dec. 26 -- Bloomberg's Trish Regan, Cory Johnson and Pimm Fox report on todays top ten stocks.
Bloomberg
Why Express Scripts Chose AbbVie Over Gilead
Dec. 22 -- Bloomberg's Drew Armstrong discusses pharmaceuticals and the health care industry with Mia Saini on Bottom Line. (Source: Bloomberg)
Bloomberg
Existing Home Sales Fall 6.1% in November
Dec. 22 -- Bloomberg's Olivia Sterns reports on todays top news stories on Money Clip.
Bloomberg
Options Insight: How to Play Gilead Sciences
July 22 -- Scott Bauer, senior market strategist at Trading Advantage, discusses the U.S. markets and his options play for Gilead Sciences. He speaks with Bloomberg's Julie Hyman on "Bloomberg Markets."
Bloomberg
Market Wrap 10/31: October S&P, Energy, Gilead
Oct.31 -- Bloomberg market reporters take a deep dive into all of the action today.
Bloomberg
Bloomberg Market Wrap 4/10: Amerisource, Macy's, Health Care
Apr.10 -- Bloomberg market reporters take a deep dive into all of today's action.